Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1995-06-07
2000-04-04
Minnifield, Nita
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4241841, 4241941, 4241931, 42419711, 4242441, 4242401, 4242361, 4242431, 4242491, 4242501, 4242561, 4242571, 4242581, 4242591, 4242601, 424831, 530402, 530403, 530395, 514 2, A61K 39085, A61K 3902, A61K 3800, C07K 100
Patent
active
060458054
ABSTRACT:
An oligosaccharide derived from an antigen polysaccharide obtained from a pathogenic agent, a method for its preparation, and its use particularly as a vaccinal agent. The oligosaccharide is prepared by oxidation-reduction depolymerization reaction.
REFERENCES:
patent: 4356170 (1982-10-01), Jennings et al.
patent: 4663160 (1987-05-01), Tsay
patent: 4673574 (1987-06-01), Anderson
patent: 4711779 (1987-12-01), Porro et al.
patent: 4727136 (1988-02-01), Jennings et al.
patent: 4762713 (1988-08-01), Anderson
patent: 4808700 (1989-02-01), Anderson
patent: 5122450 (1992-06-01), Feizi et al.
patent: 5153312 (1992-10-01), Porro et al.
patent: 5204098 (1993-04-01), Szu et al.
patent: 5302386 (1994-04-01), Kasper et al.
patent: 5306492 (1994-04-01), Porro et al.
patent: 5370872 (1994-12-01), Cryz et al.
patent: 5445817 (1995-08-01), Schneerson et al.
patent: 5476929 (1995-12-01), Briles et al.
Porro et al, Medicine Tropicals, 43(2), 129(1983.
Porro et al, Molecular Immunology, 22(8), 907 (1985).
Meikle and Bundle, Glycoconjugate J., 7, 207 (1990).
Uchida et al, "Oxidative depolymerisation of polymerisation of polysaccharides induced by the ascorbic acid-copper ion systems", Agricultural and Biological Chemistry, vol. 50, No. 10, 1986. pp. 2579-2583.
Paoletti et al, "An oligosaccharide-tetanus toxoid conjugate vaccine against type iii group b streptococcus", Journal of Biological Chemistry, vol. 265, No. 30, 1990, pp. 18278-18283.
Szu et al, "Ultrasonic irradiation of bacterial polysaccharides, characterization of the depolymerized products and some applications of the process", Carbohydrate Research, vol. 152, 1986, pp. 7-20.
Edelman et al. 1990. Int. Rev. Immunol. 7:51-66.
Schneerson et al. 1992. Inf & Imm. 60(9): 3528-3532.
Cryz et al. 1990 Inf & Imm. 58(2):373-77.
Langer Science 1990. 249:1528-33.
Anderson et al. 1985 J. Clin. Invest. 76:52-59.
Munson. 1990. Can. J. Vet. Res. 54:S63-S67.
Lee et al. 1994. Vaccine 12(10):875-78.
Fattom et al. 1990. Inf & Imm. 58(7):2367-74.
Aron et al. 1993. J. Clin. Microbiol. 31(4):975-978.
Schneerson et al. 1980. J. Exp. Med. 152:361-376.
Jennings. 1992. J. Inf. Dis. 165(Suppl 1):S156-S159.
Szu. et al. 1989 Inf & Imm. 57(12):3823-27.
Szu et al. 1987. J. Exp. Med. 166:1510-1524.
Sarvas et al. 1988. Scand. J. Immunol 28:471-479.
Haynes 1993 Science 260:1279-1286.
Fox 1994 Bio/Technology 12:128.
Minnifield Nita
Pasteur Merieux Serums et Vaccines
LandOfFree
Oligosaccharide derived from an antigenic polysaccharide obtaine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligosaccharide derived from an antigenic polysaccharide obtaine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligosaccharide derived from an antigenic polysaccharide obtaine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-362365